Opko Health OPK
NASDAQ OPK
$1.62 -0.04 (-2.71%)
As of: Oct 21, 2026 · 3:20 PM EDT

Opko Health (OPK) Current Deferred Revenue (2023 - 2024)

Updated

Opko Health (OPK) posted Current Deferred Revenue of $6,000 for Q4 2024, down 14.3% from $7,000 a year earlier.

Analysis

Opko Health (OPK) Current Deferred Revenue (2023 - 2024) Analysis & Trends

  • In prior years, Opko Health's Current Deferred Revenue was $7,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.48 Bn 1,106.07 Bn 19.71 Bn
2 Johnson & Johnson 618.81 Bn 537.34 Bn 17.26 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn
7 Amgen 236.67 Bn 192.07 Bn 7.24 Bn
8 Gilead Sciences 191.16 Bn 165.36 Bn 6.22 Bn
9 Pfizer 169.69 Bn 116.34 Bn 10.94 Bn
10 Opko Health 1.22 Bn -207.16 Mn 80.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 6,000.00
Dec 31, 2023 7,000.00
API Access

Opko Health Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OPK&period=max&api_key=YOUR_API_KEY